The cost of asthma medicines
- PMID: 29670308
- PMCID: PMC5895474
- DOI: 10.18773/austprescr.2018.011
The cost of asthma medicines
Keywords: asthma; cost of drugs; medication adherence.
Conflict of interest statement
Helen Reddel has received honoraria for providing independent advice on advisory boards, steering committees and data safety monitoring boards for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck and Novartis. She has received honoraria for independent consulting for AstraZeneca and GlaxoSmithKline, and for providing independent medical education at symposia funded by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mundipharma, Novartis and Teva. Professor Reddel has received independent research grants from AstraZeneca and GlaxoSmithKline. Nicholas Zwar has received independent research funding from GlaxoSmithKline.
References
-
- National Asthma Council Australia. Australian asthma handbook, version 1.3. Melbourne: National Asthma Council Australia; 2017. http://www.asthmahandbook.org.au [cited 2018 Jan 11]
-
- Correll PK, Poulos LM, Ampon R, Reddel HK, Marks GB. Respiratory medication use in Australia 2003–2013: treatment of asthma and COPD. Canberra: Australian Institute of Health and Welfare; 2015. https://www.aihw.gov.au/getmedia/24a0baf9-1298-4178-8f42-66d71fc2df34/18... [cited 2018 Jan 11]
-
- Reddel HK, Beckert L, Moran A, Ingham T, Ampon RD, Peters MJ, et al. Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia. Respirology 2017;22:1570-8. 10.1111/resp.13123 - DOI - PubMed
-
- Ampon RD, Reddel HK, Correll PK, Poulos LM, Marks GB. Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease. Med J Aust 2009;191:319-23. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19769554 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources